AngioDynamics(ANGO)

产业链观察04-04 20:29

#药闻简讯# 美国FDA已经批准了$AngioDynamics(ANGO)$ 用于治疗肺栓塞（PE）的AlphaVac F1885系统，增强了其在PE等关键医疗场景中的实用性。查看全文

持股变动声明

AngioDynamics(ANGO)04-09 04:35

$AngioDynamics(ANGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-24-018620  Size: 4 KB 网页链接查看全文

季度财报

AngioDynamics(ANGO)04-10 05:15

$AngioDynamics(ANGO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-24-015487  Act: 34  Size: 7 MB 网页链接查看全文

当期报告

AngioDynamics(ANGO)04-04 19:35

$AngioDynamics(ANGO)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001140361-24-017807  Act: 34  Size: 5 MB 网页链接查看全文

当期报告

AngioDynamics(ANGO)04-02 05:35

$AngioDynamics(ANGO)$ 8-K Current report, item 1.01 Accession Number: 0001140361-24-016977  Act: 34  Size: 159 KB 网页链接查看全文

持股变动声明

AngioDynamics(ANGO)03-05 09:55

$AngioDynamics(ANGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-24-011190  Size: 4 KB 网页链接查看全文

当期报告

AngioDynamics(ANGO)02-14 05:15

$AngioDynamics(ANGO)$ 8-K Current report, item 5.02 Accession Number: 0001140361-24-007427  Act: 34  Size: 159 KB 网页链接查看全文

超过5%股东持股披露「修订」

AngioDynamics(ANGO)02-09 23:05

$AngioDynamics(ANGO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000354204-24-002930  Act: 34  Size: 19 KB 网页链接查看全文

超过5%股东持股披露「修订」

AngioDynamics(ANGO)02-14 06:05

$AngioDynamics(ANGO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-020288  Act: 34  Size: 12 KB 网页链接查看全文

HeartCopilot01-27 11:57

AngioDynamics近日宣布，美国食品和药物管理局（FDA）已批准Auryon XL导管（一种225cm的径向通路导管）与Auryon斑块切除术系统一起用于治疗外周动脉疾病（PAD）。
研究表明，在治疗 PAD 患者时，与股骨通路相比，径向通路与大出血和通路部位并发症的风险显着降低相关。
AngioDynamics的A...查看全文

季度财报

$AngioDynamics(ANGO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-24-015487  Act: 34  Size: 7 MB 网页链接

持股变动声明

$AngioDynamics(ANGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-24-018620  Size: 4 KB 网页链接

当期报告

$AngioDynamics(ANGO)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001140361-24-017807  Act: 34  Size: 5 MB 网页链接

当期报告

$AngioDynamics(ANGO)$ 8-K Current report, item 1.01 Accession Number: 0001140361-24-016977  Act: 34  Size: 159 KB 网页链接

持股变动声明

$AngioDynamics(ANGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-24-011190  Size: 4 KB 网页链接

超过5%股东持股披露「修订」

$AngioDynamics(ANGO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-020288  Act: 34  Size: 12 KB 网页链接

当期报告

$AngioDynamics(ANGO)$ 8-K Current report, item 5.02 Accession Number: 0001140361-24-007427  Act: 34  Size: 159 KB 网页链接

超过5%股东持股披露「修订」

$AngioDynamics(ANGO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000354204-24-002930  Act: 34  Size: 19 KB 网页链接

超过5%股东持股披露「修订」

$AngioDynamics(ANGO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-001727  Act: 34  Size: 13 KB 网页链接

超过5%股东持股披露「修订」

$AngioDynamics(ANGO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001273087-24-000023  Act: 34  Size: 81 KB 网页链接